A synthetic lipid A analog, B464, provides significant protection against the cardiopulmonary derangements in porcine Gram-negative sepsis

Journal of Endotoxin Research

Volumn 2, Issue 2, 1995, Pages 121-130

  Ridings, P ^a   Windsor, A C ^a   Rossignol, D P ^a   Christ, W J ^a   Blocher, C ^a   Fisher, B J ^a   Fowler, A A ^a   Sugerman, H J ^a  

^a EISAI RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B 464; ENDOTOXIN; LIPID A DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CONTROLLED STUDY; ENDOTOXEMIA; GRAM NEGATIVE BACTERIUM; HEMODYNAMICS; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEPSIS; SWINE;

EID: 0029004986     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199500200207     Document Type: Article

References (36)

1. Fowler AA, Hamman RF, Zerbe GO, Benson KN, Hyers TM Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis 1985; 132: 472-478.
2. Wenzel RP The mortality of hospital-acquired bloodstream infections: Need for a new vital statistic? Int J Epidemiol 1988; 17: 225-227.
3. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986; 133: 913-927.
4. Suffredini AF, Fromm RE, Parker MM et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989: 321: 280-287.
5. Galanos CO, Luderitz ET, Rietschel O. et al. Synthetic and natural E. coli free lipid A express identical endotoxic activities. Eur J Biochem 1985; 148: 1-5.
6. Adams JL, Czuprynski CJ Bacterial lipopolysaccharide induces release of tumor necrosis factor-alpha from bovine peripheral blood monocytes and alveolar macrophages in vitro. J Leukoc Biol 1990; 48: 549-556.
7. Loppnow H., Brade H., Durrbaum I. et al. IL-1 induction capacity of defined lipopolysaccharide partial structures. J Immunol 1989; 142: 3229-3238.
8. Tracey KJ, Beutler B., Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
9. Golenbock DT, Will JA, Raetz Chr, Proctor RA Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin. Infect Immun 1987; 55: 2471-2476.
10. Nishijama M., Amano F., Akamatsu Y., Akagawa K., Tokunaga T., Raetz Chr. Macrophage activation by monosaccharide precursors of Escherichia coli lipid A. Proc Natl Acad Sci USA 1985; 82: 282-286.
11. Loppnow H., Libby P., Freudenberg M., Krauss JH, Weckesser J., Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990; 58: 3743-3750.
12. Golenbock DT, Hampton RY, Qureshi N., Takayama K., Raetz CR Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490-19498.
13. Takayama K., Qureshi N., Beutler B., Kirkland TN Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect Immun 1989; 57: 1336-1338.
14. Byrne K., Sugerman HJ Experimental and clinical assessment of lung injury by measurement of extravascular lung water and transcapillary protein flux in ARDS: A review of current techniques. J Surg Res 1988; 44: 185-203.
15. Sorensen K., Brodbeck U. A sensitive protein assay method using microtiter plates. Experimentia 1986; 42: 161-162.
16. Holloway BW, Krishnapillen V., Moya AF Chromosomal genetics of Pseudomonas aeruginosa. Microbiol Rev 1979; 43: 73-102.
17. Natanson C., Eichenholz PW, Danner RL et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169: 823-832.
18. Raetz Crh. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-170.
19. Lynn WA, Raetz CR, Qureshi N., Golenbock DT Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. J Immunol 1991; 147: 3072-3079.
20. Beutler B., Milsark IW, Cerami AC Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-871.
21. Ishii Y., Wang Y., Haziot A., del Vecchio PJ, Goyert SM, Malik AB Lipopolysaccharide binding protein and CD14 interaction induces tumor necrosis factor-alpha generation and neutrophil sequestration in lungs after intratracheal endotoxin. Circ Res 1993; 73: 15-23.
22. Haziot A., Tsuberi BZ, Goyert SM Neutrophil CD14: Biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 1993; 150: 5556-5565.
23. Wang SC, Rossignol DP, Christ WJ et al. Suppression of LPS-induced nitric oxide production in vitro by a novel LPS antagonist. Surgery 1994; In press.
24. Rossignol DP, Rose J., Kawata T., Bristol J., Christ WJ, Kishi Y. Novel synthetic non-toxic lipid A derivatives that inhibit endotoxin binding and activation of human monocyte-derived macrophages. Pharmacol 1993; 35: 197-202.
25. Windsor AC, Walsh CJ, Mullen PG et al. TNF blockade prevents neutrophil CD 18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 1993; 91: 1459-1468.
26. Windsor Acj, Mullen PG, Walsh CJ et al. Delayed tumor necrosis factor blockade attenuates pulmonary dysfunction and metabolic acidosis associated with experimental Gram-negative sepsis. Arch Surg 1994; 129: 80-89.
27. Olson NC, Kruse Elliott KT, Dodam JR Systemic and pulmonary reactions in swine with endotoxemia and Gram-negative bacteremia. J Am Vet Med Assoc 1992; 200: 1870-1884.
28. Walsh CJ, Sugerman HJ, Mullen PG et al. Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine Gram-negative sepsis. Arch Surg 1992; 127: 138-144.
29. Carey PD, Leeper Woodford SK, Walsh CJ, Byrne K., Fowler AA, Sugerman HJ Delayed cyclo-oxygenase blockade reduces the neutrophil respiratory burst and plasma tumor necrosis factor levels in sepsis-induced acute lung injury. J Trauma 1991; 31: 733-740.
30. Walsh CJ, Carey PD, Cook DJ, Bechard DE, Fowler AA, Sugerman HJ Anti-CD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during Gram-negative sepsis. Surgery 1991; 110: 205-211.
31. Carey PD, Byrne K., Jenkins JK et al. Ibuprofen attenuates hypochlorous acid production from neutrophils in porcine acute lung injury. J Surg Res 1990; 49: 262-270.
32. Lynn M. Sensakovic JW, Bartell PF In vivo distribution of Pseudomonas aeruginosa slime glycoprotein: Association with leukocytes. Infect Immun 1977; 15: 109-114.
33. Van Devort M., Doerfler E., Steutz P., Danner RL Antagonism of LPS-induced priming of human neutrophils by lipid A analogues. J Immunol 1992; 149: 359-366.
34. Doerfler ME, Danner RL, Shelhammer JH, Parrillo JE Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4. J Clin Invest 1989; 83: 970-977.
35. Aida Y., Pabst MJ Neutrophil responses to lipopolysaccharide; effect of adherence on triggering and priming of the respiratory burst. J Immunol 1991; 146: 1271-1276.
36. Woods DE, Cryz SJ, Freidman RL, Iglewski BH Role of exotoxin and elastase as possible virulence factors in experimental infections with Pseudomonas aeruginosa. Infect Immun 1978; 19: 839-845.